Q2 Results: Dr Lal PathLabs Reports 24.8% Drop In Net Profit, Consolidated Revenue At Rs 534 Cr
Dr Lal Path Labs, the leading diagnostic company in India has announced its earnings for the quarter that ended on 30th September 2022, the diagnostic giant has posted a consolidated revenue of Rs 534 crores.
The company has recorded a rise of 7.1 per cent against the corresponding quarter earnings last year which stood at Rs 498 crores. Though the company reported a 6.2 per cent decline in its year-on-year consolidated revenue earnings.
The diagnostic company has posted a 24.8 per cent drop in its net profit of Rs 72.4 crores for Quarter Two of the Financial Year 2023 (Q2FY23), from Rs 96.3 crores that the company secured in the same quarter last year.
On the year-on-year basis, the company recorded a 43.2 per cent dip in its net profits.
Dr Lal's EBTIDA grew by 1.6 per cent to be recorded at Rs 143.8 crores for the second quarter against the corresponding quarter's figure which stood at Rs 141.5 crores, whereas the company's EBTIDA margin dipped to 26.9 per cent for the September quarter from 28.4 per cent in the same quarter last year.
The company in a statement said that its non-Covid revenue increased by 14.8 per cent in Q2 FY23 to Rs 514 crores compared with Rs 448 crores in Q2 FY22.
The company’s stock traded at Rs 2,625.60 a piece, a high of 1.78 per cent as of 14:53 IST (Indian Standard Time).
